Risk Factors Associated with Pain on Chronic Intermittent Hemodialysis: A Systematic Review

被引:17
作者
Brkovic, Tonci [1 ]
Burilovic, Eliana [2 ]
Puljak, Livia [3 ]
机构
[1] Univ Hosp Split, Div Nephrol & Hemodialysis, Dept Internal Med, Split, Croatia
[2] Univ Hosp Split, Dept Psychiat, Split, Croatia
[3] Univ Split, Lab Pain Res, Sch Med, Soltanska 2, Split 21000, Croatia
关键词
pain; hemodialysis; STAGE RENAL-DISEASE; QUALITY-OF-LIFE; SUBCUTANEOUS INJECTION; BUTTONHOLE CANNULATION; PARATHYROID-HORMONE; DARBEPOETIN-ALPHA; SHOULDER PAIN; EPOETIN-BETA; CROSS-OVER; DIALYSIS;
D O I
10.1111/papr.12594
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
ObjectivesThe aim of the study was to define risk factors related to pain in adult end-stage renal disease (ESRD) patients on chronic intermittent hemodialysis (HD) by developing a systematic review of published data. MethodsThe search was conducted from MEDLINE, Scopus, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). Manuscripts in all languages were considered. Two authors performed each step independently, and all disagreements were resolved after discussion with the third author. Quality of studies was analyzed using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist and Cochrane risk of bias tool. ResultsA total of 67 studies with 7,818 participants were included (median number of participants=60). Most of the studies reported common factors such as age, gender, body mass index, race/ethnicity, marital status, duration of HD treatment since initiation of HD, different comorbidities, and biochemical parameters. Other studies reported more specific factors such as type, regimen or place of hemodialysis, type of dialyzer, dialysis phase, type of dialyzer membrane, administration site, type of preparation, and dose of erythropoiesis-stimulating agent (ESA). The studies indicate that these factors may contribute to increased pain in general and also promote development of different pain modalities of various locations and causes in HD patients (eg, pain in general, pain related to arteriovenous access, headache, musculoskeletal pain, ESA application pain). DiscussionMultiple factors for various types of pain in very heterogeneous populations and heterogeneous settings were analyzed in the literature. The results turned out to be inconsistent between the studies. Future large-scale studies are required, taking into the account limitations of the current evidence base.
引用
收藏
页码:247 / 268
页数:22
相关论文
共 88 条
[1]  
ABEL JJ, 1990, TRANSFUS SCI, V11, P164
[2]   Pain resulting from arteriovenous fistulae: prevalence and impact [J].
Aitken, Emma ;
McLellan, Angus ;
Glen, Julie ;
Serpell, Mick ;
Mactier, Robert ;
Clancy, Marc .
CLINICAL NEPHROLOGY, 2013, 80 (05) :328-333
[3]   Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache [J].
Alessandri, M. ;
Massanti, L. ;
Geppetti, P. ;
Bellucci, G. ;
Cipriani, M. ;
Fanciullacci, M. .
CEPHALALGIA, 2006, 26 (11) :1287-1293
[4]   Prospective evaluation of an in-center daily hemodialysis program -: Results of two years of treatment [J].
André, MB ;
Rembold, SM ;
Pereira, CM ;
Lugon, JR .
AMERICAN JOURNAL OF NEPHROLOGY, 2002, 22 (5-6) :473-479
[5]  
[Anonymous], REV SOC ESP ENFERM N
[6]  
[Anonymous], REV SOC ESP ENFERM N
[7]  
[Anonymous], SUST REV CRDS GUID U
[8]  
[Anonymous], COCHRANE DATABASE SY
[9]  
[Anonymous], METAS ENFERM
[10]  
[Anonymous], OXFORD HDB DIALYSIS